Rik J. Deitsch is the Chief Executive Officer of Nutra Pharma Corp., a biopharmaceutical company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, autoimmune and infectious diseases as well as pain management. The company currently markets drugs for the treatment of pain in humans and animals. They are also conducting clinical trials for RPI-78M: a first-in-class treatment for Multiple Sclerosis (MS) for which they have already received Orphan Designation for pediatric MS.  

Rik was formerly in the Product Development department of the Rexall Sundown company and developed over 50 dietary supplements for the company. He currently operates Pure Raw Supplies, a company that creates and manufactures dietary supplements with clinical support that includes a line of zeolite mineral detoxifying agents.  

Rik holds a B.S. in chemistry from Florida Atlantic University and has conducted research in collaboration with the Duke University Medical School Comprehensive Cancer Center and the Cleveland Clinic Cardiology Department. In addition, Rik has served as an adjunct professor and taught several courses for FAU’s College of Business and Continuing Education Department. He is also the co-author of two books, Are You Age-Wise, a guide to healthy aging, and Invisible Killers, a guide to environmental toxicity. 

“Florida Atlantic University provided me with the foundations for a successful career in biotech, management and as an entrepreneur. The laboratory and real world skills learned at FAU led directly to my creation of several new therapies for pain and inflammation. Additionally, FAU provided me the opportunity to teach courses in the College of Science, as well as the College of Business and Continuing Education. That teaching experience served me well as a lecturer, presenter and CEO of a public company.”

Erik (Rik) J. Deitsch, B.S. ’97